TR199701121T1 - Benazepril veya benazeprilat ve valsartan i�eren kombinasyon bile�imleri. - Google Patents

Benazepril veya benazeprilat ve valsartan i�eren kombinasyon bile�imleri.

Info

Publication number
TR199701121T1
TR199701121T1 TR97/01121T TR9701121T TR199701121T1 TR 199701121 T1 TR199701121 T1 TR 199701121T1 TR 97/01121 T TR97/01121 T TR 97/01121T TR 9701121 T TR9701121 T TR 9701121T TR 199701121 T1 TR199701121 T1 TR 199701121T1
Authority
TR
Turkey
Prior art keywords
benazepril
valsartan
compositions containing
combination compositions
formula
Prior art date
Application number
TR97/01121T
Other languages
English (en)
Turkish (tr)
Inventor
De Gasparo Marc
Lee Webb Randy
Saul Cohen David
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of TR199701121T1 publication Critical patent/TR199701121T1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/55—Protease inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/55—Protease inhibitors
    • A61K38/556—Angiotensin converting enzyme inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
TR97/01121T 1995-04-07 1996-04-02 Benazepril veya benazeprilat ve valsartan i�eren kombinasyon bile�imleri. TR199701121T1 (xx)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH101295 1995-04-07

Publications (1)

Publication Number Publication Date
TR199701121T1 true TR199701121T1 (xx) 1998-03-21

Family

ID=4200393

Family Applications (1)

Application Number Title Priority Date Filing Date
TR97/01121T TR199701121T1 (xx) 1995-04-07 1996-04-02 Benazepril veya benazeprilat ve valsartan i�eren kombinasyon bile�imleri.

Country Status (15)

Country Link
EP (1) EP0820302A1 (fr)
JP (1) JPH11503139A (fr)
KR (1) KR19980703647A (fr)
CN (1) CN1181019A (fr)
AU (1) AU5399096A (fr)
BR (1) BR9604818A (fr)
CA (1) CA2214143A1 (fr)
CZ (1) CZ313897A3 (fr)
HU (1) HUP9801593A2 (fr)
MX (1) MX9707683A (fr)
NO (1) NO974400D0 (fr)
PL (1) PL322529A1 (fr)
SK (1) SK133897A3 (fr)
TR (1) TR199701121T1 (fr)
WO (1) WO1996031234A1 (fr)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2224451A1 (fr) * 1995-06-30 1997-01-23 Merck & Co., Inc. Procede de traitement de nephropathies a l'aide d'un inhibiteur de l'ace et d'un antagoniste de l'a ii
CN101011390A (zh) 1999-01-26 2007-08-08 诺瓦提斯公司 血管紧张素ⅱ受体拮抗剂在治疗急性心肌梗塞中的应用
HUP0400475A3 (en) * 2000-04-12 2006-02-28 Novartis Ag Pharmaceutical compositions containing combination of at least two compounds selected from an at1-receptor antagonist or an ace inhibitor or a hmg-co-a reductase inhibitor groups and use thereof
AU2001289672B2 (en) 2000-07-19 2005-12-08 Novartis Ag Valsartan salts
GB0020691D0 (en) * 2000-08-22 2000-10-11 Boehringer Ingelheim Pharma Pharmaceutical combination
PL366419A1 (en) * 2000-08-22 2005-01-24 Boehringer Ingelheim Pharma Bmbh & Co.Kg Pharmaceutical combination of angiotensin ii antagonists and angiotensin i converting enzyme inhibitors
CZ20031678A3 (cs) * 2000-12-18 2003-10-15 Novartis Ag Terapeutická kombinace amlodipinu a benazeprilu
US6869970B2 (en) * 2002-02-04 2005-03-22 Novartis Ag Crystalline salt forms of valsartan
CN100377744C (zh) * 2002-07-05 2008-04-02 安徽省生物医学研究所 一种预测acei类降压药药效的复方药
WO2004019876A2 (fr) * 2002-08-28 2004-03-11 Curis, Inc. Administration conjointe de morphogenes et d'inhibiteurs de conversion de l'enzyme de l'angiotensine pour le traitement de l'insuffisance renale chronique
EP1908469A1 (fr) * 2006-10-06 2008-04-09 Boehringer Ingelheim Vetmedica Gmbh Antagonistes du récepteur de l'angiotensine II pour traiter des désordres sistémiques des chats
CN101869710A (zh) * 2009-04-24 2010-10-27 北京奥萨医药研究中心有限公司 降压药物组合物
WO2010133638A1 (fr) 2009-05-20 2010-11-25 Boehringer Ingelheim Vetmedica Gmbh Solution pharmaceutique buvable de telmisartan
US20110009347A1 (en) 2009-07-08 2011-01-13 Yin Liang Combination therapy for the treatment of diabetes
EP3099328A1 (fr) * 2014-01-31 2016-12-07 Janssen Pharmaceutica NV Procédés de traitement et de prévention de troubles rénaux et de troubles graisseux du foie

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR970005839B1 (ko) * 1990-05-11 1997-04-21 화이자 인코포레이티드 상승 치료효과를 얻기 위한 조성물 및 방법
EP0629408A1 (fr) * 1993-06-16 1994-12-21 LABORATOIRES MERCK, SHARP & DOHME-CHIBRET Combination d'inhibiteurs ACE et d'antagonistes AII

Also Published As

Publication number Publication date
CN1181019A (zh) 1998-05-06
HUP9801593A2 (hu) 1999-01-28
CZ313897A3 (cs) 1998-01-14
EP0820302A1 (fr) 1998-01-28
BR9604818A (pt) 1998-06-09
NO974400L (no) 1997-09-23
JPH11503139A (ja) 1999-03-23
SK133897A3 (en) 1998-02-04
PL322529A1 (en) 1998-02-02
CA2214143A1 (fr) 1996-10-10
KR19980703647A (ko) 1998-12-05
MX9707683A (es) 1997-12-31
NO974400D0 (no) 1997-09-23
WO1996031234A1 (fr) 1996-10-10
AU5399096A (en) 1996-10-23

Similar Documents

Publication Publication Date Title
DE69531457D1 (en) Sulfonamide
TR199701121T1 (xx) Benazepril veya benazeprilat ve valsartan i�eren kombinasyon bile�imleri.
MY125150A (en) Factor vlla inhibitors
DE69326776D1 (de) Verwendung von n-arylmethylen ethylendiamintriacetate, n-arylmethylen iminodiacetat oder n,n'-diarylmethylen ethylendiamindiacetat gegen oxidativen stress
SE9604786D0 (sv) New compounds
UA49869C2 (uk) Нафтил-заміщені похідні бензимідазолу, фармацевтична композиція, спосіб лікування (варіанти) та спосіб інгібування людського фактора
IL107109A0 (en) Compounds for modifying drug resistance and pharmaceutical compositions containing the same
BR9811825A (pt) Uso de lactobacillus para redução do nìvel de fibrinogênio no sangue
BG103947A (en) Derivatives of 9-oxymerythromycin
YU60900A (sh) Novi kristalni oblici antivirusnog benzimidazolskog jedinjenja
FI964332A (fi) Eräiden metaanibisfosfonihappojohdannaisten käyttö proteesin löystymisen ja proteesin vaelluksen estämiseen
MX9606503A (es) Inhibidores de pla2 y su uso para la inhibicion de la absorcion del colesterol interno.
DE69825164D1 (de) Arzneizubereitungen enthaltend vitamin d und kalzium,ihre herstellung und therapeutische verwendung
BR9713921A (pt) Composto, composição farmacêutica, processo para tógico capaz de ser modulado através da inibição do fator xa
IL131407A0 (en) Tetrahydropyrido compounds medicaments containing the same and the use thereof
BR9913285A (pt) Método de modulação das células t efetoras da memória e composições
TR200101163T2 (tr) Safra suyu ikameli fenil-alkenoilguanidinler, üretim yöntemleri, kullanımları
TR199801184T2 (xx) Analjezik tesirli yeni bile�ikler.
GB9505082D0 (en) Medicament
GB9420747D0 (en) 1,5 benzodiazepine derivatives
HUP9801894A2 (hu) Dofetilid alkalmazása kongesztív szívpanaszok kezelésére szolgáló gyógyszerkészítmények előállítására
MD980129A (en) Antiherpetic remedy
FR2754824B1 (fr) Nouvelle composition contenant du chitosan
IS5231A (is) Vefjaþáttur sem hefur áhrif á blóðæðarmyndun
EA199800953A1 (ru) Компонент в, используемый в качестве рубцующего агента, содержащая его фармацевтическая композиция и способ лечения